GLYPH Trademark

Trademark Overview


On Monday, July 5, 2021, a trademark application was filed for GLYPH with the United States Patent and Trademark Office. The USPTO has given the GLYPH trademark a serial number of 90811136. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, July 31, 2024. This trademark is owned by PureTech Health LLC. The GLYPH trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

commercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields

research and development in the pharmaceutical and biotechnology fields
glyph

General Information


Serial Number90811136
Word MarkGLYPH
Filing DateMonday, July 5, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, July 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Goods and ServicesTechnologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases
Goods and Servicescommercialization, namely, commercial consultancy in the pharmaceutical and biotechnology fields
Goods and Servicesresearch and development in the pharmaceutical and biotechnology fields

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 14, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEAPORT THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02210

Party NamePureTech Health LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02210

Party NamePureTech Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Thursday, July 8, 2021NEW APPLICATION ENTERED
Tuesday, September 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 24, 2022ASSIGNED TO EXAMINER
Tuesday, March 29, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 29, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022ASSIGNED TO EXAMINER
Tuesday, September 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 27, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 9, 2022FINAL REFUSAL WRITTEN
Wednesday, November 9, 2022FINAL REFUSAL E-MAILED
Wednesday, November 9, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, May 2, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 2, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, May 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 2, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, May 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 26, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 27, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 27, 2024SOU EXTENSION 1 FILED
Saturday, January 27, 2024SOU EXTENSION 1 GRANTED